Paul Rennie, Chairman & Managing Director at Paradigm Biopharmaceuticals Ltd., holds 20.92M shares in Paradigm Biopharmaceuticals Ltd. (Ticker: PBIGF), holds 1.09M shares in Neuroscientific Biopharmaceuticals Ltd. (Ticker: AU:NSB). Most recently, Paul Rennie Bought ― shares of Paradigm Biopharmaceuticals Ltd. on Oct 16, 2024 for an estimated value of 50.83K.
What is the percentage of profitable transactions made by Paul Rennie?
The percentage of profitable transactions made by Paul Rennie is 8%.
What is the average return per transaction made by Paul Rennie?
The average return per transaction made by Paul Rennie is -41.80%.
What stocks does Paul Rennie hold?
Paul Rennie holds: PBIGF, AU:NSB stocks.
What was Paul Rennie’s latest transaction?
Paul Rennie latest transaction was an Informative Buy of $50.83K.
What was Paul Rennie's most profitable transaction?
Paul Rennie’s most profitable transaction was an Informative Buy of PBIGF stock on March 9, 2022. The return on the trade was 20.20%.
What is Paul Rennie's role in Paradigm Biopharmaceuticals Ltd.?
Paul Rennie's role in Paradigm Biopharmaceuticals Ltd. is Chairman & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.